Botulinum Toxin Type A (BOTOX®) Treatment of Masseter Muscle Hypertrophy

Study Identifier
191622-130
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Protocol
Available Language(s): English
Statistical Analysis Plan
Available Language(s): English

Study Details

Medical Condition
  • Facial Aesthetics - Toxins
  • Study Drug
  • botulinum toxin Type A
  • Normal saline
  • Phase
    Phase 2
    Sex
    Female & Male
    Age
    18 - 50 Years

    Protocol Summary

    This study will evaluate the safety and efficacy of a range of doses of botulinum toxin Type A (BOTOX®) for the treatment of patients with bilateral Masseter Muscle Hypertrophy (MMH).

    Study Locations

    Location
    Status
    Location
    Shape Clinic
    Darlinghurst, New South Wales, Australia, 2010
    Status
    Not applicable
    Location
    Central Sydney Dermatology
    Sydney, New South Wales, Australia, 2000
    Status
    Not applicable
    Location
    Esteem Beauty & Day Spa
    Main Beach, Queensland, Australia, 4217
    Status
    Not applicable
    Location
    The Rose Medical & Aesthetic Centre
    North Fremantle, Western Australia, Australia, 6159
    Status
    Not applicable
    Location
    Dr. Jean Carruthers Cosmetic Surgery, Inc.
    Vancouver, British Columbia, Canada, V5Z 4E1
    Status
    Not applicable
    Location
    Dr. Shannon Humphrey Inc.
    Vancouver, British Columbia, Canada, V5Z 4E1
    Status
    Not applicable
    Showing {first} - {last} of {total} Results